Company Filing History:
Years Active: 2024
Title: Marina Stasenko: Innovator in Cancer Research
Introduction
Marina Stasenko is a prominent inventor based in New York, NY, who has made significant contributions to the field of cancer research. Her innovative work focuses on the development of antibodies that target galectin-3, a protein implicated in various disorders, including cancer.
Latest Patents
Stasenko holds a patent for "Antibodies to galectin-3 and methods of use thereof." This patent involves compositions, methods, and uses of antibodies that specifically bind to the carbohydrate binding domain of galectin-3 (LGALS3). The patent outlines various applications for managing, treating, or preventing disorders such as cancer, showcasing her commitment to advancing medical science.
Career Highlights
Marina Stasenko is affiliated with the Memorial Sloan Kettering Cancer Center, a leading institution in cancer treatment and research. Her work at this prestigious center allows her to collaborate with top professionals in the field and contribute to groundbreaking research.
Collaborations
Stasenko has worked alongside notable colleagues, including David Spriggs and Dharmarao Thapi. These collaborations enhance her research efforts and expand the impact of her innovations in cancer treatment.
Conclusion
Marina Stasenko's contributions to cancer research through her innovative patents and collaborations highlight her role as a key figure in the scientific community. Her work continues to pave the way for advancements in the treatment and management of cancer.